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The replication initiation protein Cdc6p forms a tight complex with Cdc28p, specifically with forms of
the kinase that are competent to promote replication initiation. We now show that potential sites of
Cdc28 phosphorylation in Cdc6p are required for the regulated destruction of Cdc6p that has been
shown to occur during the Saccharomyces cerevisiae cell cycle. Analysis of Cdc6p phosphorylation site
mutants and of the requirement for Cdc28p in an in vitro ubiquitination system suggests that targeting
of Cdc6p for degradation is more complex than previously proposed. First, phosphorylation of
N-terminal sites targets Cdc6p for polyubiquitination probably, as expected, through promoting
interaction with Cdc4p, an F box protein involved in substrate recognition by the Skp1-Cdc53-F-box
protein (SCF) ubiquitin ligase. However, in addition, mutation of a single, C-terminal site stabilizes
Cdc6p in G2 phase cells without affecting substrate recognition by SCF in vitro, demonstrating a
second and novel requirement for specific phosphorylation in degradation of Cdc6p. SCF-Cdc4p– and
N-terminal phosphorylation site–dependent ubiquitination appears to be mediated preferentially by
Clbp/Cdc28p complexes rather than by Clnp/Cdc28ps, suggesting a way in which phosphorylation
of Cdc6p might control the timing of its degradation at then end of G1 phase of the cell cycle. The
stable cdc6 mutants show no apparent replication defects in wild-type strains. However, stabilization
through mutation of three N-terminal phosphorylation sites or of the single C-terminal phosphory-
lation site leads to dominant lethality when combined with certain mutations in the anaphase-
promoting complex.
INTRODUCTION
A hallmark of eukaryotic DNA replication is that replication
is restricted to one phase of the cell cycle, S phase, and that
this replication is mediated by the coordinated firing of a
multitude of replication origins spread over many chromo-
somes. In Saccharomyces cerevisiae, replication is initiated
from hundreds of origins, and initiation depends on the
origin recognition complex (ORC), which can be detected at
origins by means of in vivo footprinting and is present at
origins throughout the cell cycle (Bell and Stillman, 1992;
Bell et al., 1993; Diffley and Cocker, 1992; Rowley et al., 1995).
At the end of mitosis the origin footprint expands, and
genetic and molecular evidence suggest that the six-subunit
ORC, Cdc6p, the six Mcms, and Cdc45p assemble at origins
to form a prereplicative complex (preRC) at this time
(Newlon, 1997). Origins are then said to be licensed for
replication (Blow and Laskey, 1988). PreRCs are subse-
quently activated by two kinases, Clb5,6p/Cdc28p and
Dbf4p/Cdc7p. Activation coincides with the return of the
origin footprint to its unlicensed state.
To maintain genomic integrity, cells must coordinate
DNA replication such that every origin of replication fires
only once per cell cycle. In S. cerevisiae, the S phase cyclin/
Cdc28ps, Clb5p/Cdc28p, and Clb6p/Cdc28p promote the
initiation of DNA replication and also prevent aberrant
reinitiation. The S phase cyclin/Cdc28 proteins appear well
before the G1–S transition but are inhibited by the presence
of Sic1p (Nasmyth, 1993, 1996; Schwob and Nasmyth, 1993;
Schwob et al., 1994; Surana et al., 1993; Dahmann et al., 1995;
Dirick et al., 1995). Destruction of Sic1p at the G1–S transition
activates the S phase cyclin/Cdc28ps, and DNA replication
follows closely upon activation, occurring earlier in the cell
cycle if Sic1p is deleted and the S phase cyclin/Cdc28ps is
prematurely activated and occurring later in the presence of
a stabilized allele of Sic1p, which maintains the S phase
cyclin/Cdc28ps in an inactive state (Schwob et al., 1994;
Verma et al., 1997a). Additionally, in the absence of S phase
cyclins, DNA replication is delayed until activation of the
mitotic cyclins Clb1–Clb4. Thus, by all in vivo measures,
initiation of DNA replication is defined by the activation of
the Clbp/Cdc28p kinases. Phosphorylation of substrates
may control origin firing in a number of ways: phosphory-
lation may cause the import or export of DNA replication
proteins from the nucleus; phosphorylation may enhance or
block the assembly of replication proteins into replication* Corresponding author. E-mail address: jcampbel@cco.caltech.edu.
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complexes; phosphorylation may trigger changes in confor-
mation and activation or inactivation of activities of initia-
tion proteins; and phosphorylation may target initiation pro-
teins for degradation. To establish which mechanisms are at
play requires identification of the substrates that are phos-
phorylated at initiation. Although one candidate, Cdc45p,
has been suggested by recent experiments (Zou and Still-
man, 1998), and ORC, Cdc6p, and the Mcms have consensus
cyclin-dependent kinase (CDK) phosphorylation sites, veri-
fication of the critical substrates has proved difficult.
As just mentioned, firing of licensed preRCs depends on
Clb/Cdc28 kinases, but formation of preRCs, by contrast, is
inhibited in the presence of Clb/Cdc28 complexes (Dah-
mann et al., 1995). Thus, once activated by Clb kinases,
origins of replication cannot refire until passage through
mitosis inhibits Clb kinases. The substrates that are phos-
phorylated by Clbp/Cdc28p and thus prevent spurious rep-
lication are also unknown.
We are interested in characterizing the substrates of the
Clbp/Cdc28ps in the triggering of initiation and the prevention
of reinitiation. We have previously shown that Cdc6p both
associates with and is phosphorylated by Clbp/Cdc28p (El-
sasser et al., 1996). The results presented here lead to the strong
inference that phosphorylation of N-terminal sequences in
Cdc6p by Clbp/Cdc28p can target Cdc6p for recognition by
Skp1-Cdc53-F-box protein (SCF)-Cdc4p and proteasomal deg-
radation. It has been shown that S. cerevisiae arrested in S or G2
degrade bulk Cdc6p rapidly, but that Cdc6p is stable as cells
progress through G1 (Piatti et al., 1995; Drury et al., 1997;
Sanchez et al., 1999). The cell cycle-dependent instability of
Cdc6p could mean that Cdc6p is degraded in a Clbp/Cdc28-
dependent manner. Cdc6p is considerably more stable in cdc4/
cdc34/cdc53 pathway mutants than in wild-type cells (Piatti et
al., 1995; Drury et al., 1997; Sanchez et al., 1999), suggesting a
role for SCF-Cdc4p in Cdc6p turnover. Cdc6p is also stabilized
by deleting the N terminus, a region involved in Cdc28 bind-
ing, phosphorylation by Cdc28, nuclear localization, restraint
of aberrant mitosis, and Cdc4p binding (Elsasser et al., 1996;
Jong et al., 1996; Drury et al., 1997; Weinreich et al., 1999). As
expected from the stability in cdc4 mutants, Cdc6p is ubiquiti-
nated in vivo in a Cdc4-dependent manner (Sanchez et al.,
1999). Using an in vitro ubiquitination system combined with a
collection of new cdc6 alleles, we set out to explore the role of
phosphorylation of Cdc6p in Cdc4p-dependent ubiquitination.
We have correlated these findings with the effects of the mu-
tations on Cdc6p stability in G2 phase. We confirm a role for
the N terminus in targeting Cdc6p for degradation by the
SCF-Cdc4p-mediated ubiquitination pathway and demon-
strate a requirement for phosphorylation by either Clnp or
Clbp kinases. However, the behavior of several of the cdc6
mutants suggests that the regulation of Cdc6p turnover cannot
be entirely accounted for by SCF-Cdc4p–mediated ubiquitina-
tion, as had been suggested to date. This may indicate either a
direct or indirect role for the anaphase-promoting complex
(APC) (Peters, 1999) as well as SCF in regulation of Cdc6p
function.
MATERIALS AND METHODS
Media
The following abbreviations are used for yeast media: YPD (1%
Bacto-yeast extract, 2% Bacto-peptone, 2% dextrose), YPR (1%
Bacto-yeast extract, 2% Bacto-peptone, 2% raffinose), YPG
(1% Bacto-yeast extract, 2% Bacto-peptone, 2% galactose), SD minus
uracil (2% dextrose, 7.5% yeast nitrogen base, 0.5% casamino acids,
20 mg/l adenine sulfate, 20 mg/l tryptophan), SR minus uracil (2%
raffinose, 7.5% yeast nitrogen base, 0.5% casamino acids, 20 mg/l
adenine sulfate, 20 mg/l tryptophan), and SD minus leucine (2%
dextrose, 7.5% yeast nitrogen base, 0.6 g/l CSM-his-leu-trp-ura
[Bio101, Vista, CA], 20 mg/l histidine, 20 mg/l tryptophan, 20 mg/l
uracil).
Strains
The strains used in this work include BJ2168 (a prc1-407 prb1-1122 pep4-3
leu2 trp1 ura3-52), BJ5459 (a ura3-52 trp1 lys2-801 leu2D1 his3D200 pep4::HIS3
prb1D1.6R can1 GAL) (Yeast Genetic Stock Center, Berkeley, CA), RJD635
(a ura3 leu2 trp1 pep4::TRP1 cdc28::CDC28-HA::TRP1 bar1::LEU2) (Elsasser
et al., 1996), RJD885 (a ura3 leu2 trp1 cln1::URA3 cln2::LEU2 cln3::URA3
leu2::GAL-CLN3::LEU2 pep4::TRP1 cdc28::CDC28-HA::HIS3) (Verma et al.,
1997b), RJD893 (a cdc4 ura3 leu2 trp1 cln1::URA3 cln2::LEU2 cln3::URA3
leu2::GAL-CLN3::LEU2 pep4::TRP1 cdc28::CDC28-HA::HIS3), L40 (a
his3D200 trp1-901 leu2-3112 ade2 lys2-801 URA3::(lexA OP)8-LacZ
LYS2::(lexA OP)4-HIS3), and JLC1402 (cdc16-26/cdc16-264 ura3/ura3
leu2/leu2 trp1/trp1) (from K. Heichman, Myriad Genetics, Salt Lake
City, UT).
Plasmids
Preparation of Vectors with the GAL1,10 Promoter (All Constructs
with GAL Promoter). Yeast and Bluescript (Stratagene, La Jolla, CA)
plasmids bearing the GAL promoter flanked by SacI and BamHI sites
were prepared as follows. pBM150 (Johnston and Davis, 1984) was
cut with EcoRI, and an oligonucleotide cassette composed of SE25
and SE26 (Table 1) was cloned in. This oligocassette has ends that
anneal to the EcoRI ends but are designed such that the EcoRI sites
are not regenerated, and the double-stranded region of the cassette
contains a SacI site. The GAL promoter was excised with SacI and
BamHI and cloned into the same sites in pBluescript SK(2), result-
ing in pELS42, and into the same sites in the yeast-integrating vector
with a URA3-selectable marker, pRS306 (Sikorski and Hieter, 1989),
resulting in pELS89.
Introduction of a Multiple myc Tag at the C Terminus of CDC6. A
Bluescript-based vector containing the coding region for a multiple
myc epitope tag was generated by ligation of a cassette composed of
oligonucleotides SE53 and SE54 (Table 1) and cloning these ladders
into the SpeI site of pBluescript SK(2). A construct containing seven
head-to-tail myc tags, pELS47, was selected for preparation of poly-
myc-tagged CDC6. A fragment encoding residues 392–513 of CDC6
(from the StyI site to the last residue) fused to a multiple myc tag
was generated by recombinant PCR using oligonucleotides SE61
through SE64 and templates pELS47 and pELS20 (Elsasser et al.,
1996). The resulting PCR product was cloned into the SacI and SpeI
sites of pBluescript SK(2), generating pELS55. Sequencing of the
PCR product revealed that two extra myc tags had been created
during the course of the PCR reaction.
Preparation of Yeast Vectors Expressing Small N-terminal Dele-
tions of CDC6 (Figure 1). pRS315-based vectors (ARS1, CEN4, and
LEU2) (Sikorski and Hieter, 1989) for the expression of CDC6 alleles
with small deletions in the N terminus were assembled from three
fragments: the GAL promoter, N-terminal fragments (from residue
1 to 48) bearing various mutations, and a fragment (from residue 47
to 513) bearing the C terminus of CDC6 fused the Myc9 epitope tag.
Mutagenesis of the N terminus of CDC6 was accomplished as
follows. The region of CDC6 encoding the first 48 residues of the
protein was excised from pKTU6 (Elsasser et al., 1996) with BamHI
and PstI and cloned into the same sites in pBluescript SK(2), gen-
erating pELS12. (The sequence near the start of the open reading
frame (ORF) is GGATCCCATATG, where the start codon is under-
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lined.) pELS12 was transformed into CJ236 (dut 2 ung 2), and
single-stranded DNA was prepared from this strain. Deletions
within the C-terminal 46 amino acids were prepared with the oli-
gonucleotide primers indicated in Table 2 using the Muta-Gene
mutagenesis kit (Bio-Rad, Hercules, CA) yielding pELS32 (D3–16),
pELS33 (D13–26), pELS34 (D23–26), and pELS52 (D33–46). The GAL
promoter was cloned in front of the mutated N termini by inserting
the SacI–BamHI fragment derived from pELS42 (above), generating
plasmids pELS64 (wild type), pELS68 (D3–16), pELS65 (D13–26),
pELS69 (D23–26), and pELS66 (D33–46). A Bluescript-based con-
struct bearing the CDC6 ORF from residues 47 to 513 fused in frame
with the Myc9 tag was generated by excising the natural C terminus
with StyI and SpeI from pELS51, a bacterial vector bearing the CDC6
ORF from residues 47 to 513 followed by 300 bases of the natural 39
untranslated region (UTR), and cloning in the epitope-tagged C-
terminus from pELS55, resulting in pELS60. pELS60 was cut with
PstI and HindIII, excising a fragment containing residues 47–513 of
CDC6 fused to the Myc9 tag, followed by the natural 39 UTR and
cloned into pRS315, resulting in pELS63. Fragments bearing the
GAL promoter followed by the N-terminal amino acids (from
pELS64 through pELS69, described above) were cloned into
pELS63, generating pELS71 (wild type), pELS72 (D3–16), pELS73
(D13–26), pELS74 (D23–26), and pELS75 (D33–46).
Preparation of Vectors Containing the Entire CDC6 ORF and C-
terminal Myc9 Epitope Tag. Bluescript-based constructs bearing the
entire CDC6 ORF were generated by cloning the PstI–HindIII frag-
ment from pELS60 (containing the CDC6 ORF from residue 47 to
513 fused to the Myc9 tag, followed by the natural 39 UTR) into the
Table 1. Oligonucleotides
Oligonucleotide Sequence
SE25 AATTGGCCGAGCTCC
SE26 AATTGGAGCTCGGCC
SE27 GATCCGGCATATGGGCGGCCTGCA
SE28 GGCCGCCCATATGCCG
SE37 GGCCAAAGCTTCAATTGTACCCCACCTC
SE45 GGATCCCATATGTCATTTGACGATGCTCCAG
SE46 CCAACTAAGCGTATCCCTTTGAAAAGAAAAAAGTTGC
SE47 CGATGCTCCAGCAGATGTTACACCAGAATC
SE48 CGACCTTTGAAAAGAAAAAAGCTGCAGTTTGGCTC
SE53 CTAGCGAACAAAAGTTGATTTCTGAAGAAGATTTGC
SE54 CTAGGCAAATCTTCTTCAGAAATCAACTTTTGTTCG
SE61 GCGAGCTCTGAACTACATAGCC
SE62 TGACTAGTGGGCCGCTCTAGAACT
SE63 GAAACCTTTCCTTCACCCCGGGGGTTCCACTAGC
SE64 GCTAGTGGAACCCCCGGGGTGAAGGAAAGGTTTC
SE72 CCTCCACGACCTTTGGCAGCAGCAGCGTTGCAGTTCACAGAT
SE74 TATGTCAGCTATACCAATAACTCTGCA
SE75 GAGTTATTGGTATAGCTGACA
SE84 GCTCCAGCAGCGCCTCCACGA
SE97 GCTATACCAATAGCCCAACTAAGCGT
SE98 ACACCAGAATCAGCGCCAGAAAAACTG
SE99 TTGTCGCTCTCCGCGCCACGCTCGAAG
SE100 CGGTTTCTGCTTGCGCCAACAAGAGGA
SE101 ACGCCAACTACTGCGCCGGTAAAGAAA
SE102 GGCGGCCGCAATACGACTCACTATAGGGATGTCAGCTATACCAATA
SE103 TTGAAACCTTTCCTTCACTAGTCAGCTAATAGATTTATT
SE108 GGATCCTAATACGACTCACTATAGGAACAGACCACCATGGCAGCTATACCAATAACTCCAACT
SE128 GGGGATCCGTATGTCAGCTATACCAATAACTCC
SE129 GGGGATCCGTATGTCAGCTATACCAATAGCTC
SE130 GGGGATCCGTATGTCATTTGACGATGCTCC
SE131 GGGGATCCGTCTGCAGTTTGGCTCACAG
SE132 GGGGGATCCTCACTAGTGAAGGAAAGGTTTCAAAATTGAAAT
SE133 GGGGGTCGACTCACTAGTGAAGGAAAGGTTTCAAAATTGAAAT
SE134 GGATCCTAATACGACTCACTATAGGAACAGACCACCATGGCAGCTATACCAATAACTCTGCAG
SE135 GGATCCTAATACGACTCACTATAGGAACAGACCACCATGGCATTTGACGATGCTCCAGCAACG
SE136 GGATCCTAATACGACTCACTATAGGAACAGACCACCATGGCAGCTATACCAATAGCGCCAACT
Table 2. Mutagenic oligonucleotides
Sites mutated Mutation
Oligonucleotide
mutagenesis
DN terminus D8–48
D3–16 D3–16 SE45
D13–26 D13–26 SE46
D23–36 D23–36 SE47
D33–46 D33–46 SE48
NLS K29A, R30A, K31A, K32A SE72
A T7A SE97
B T23A SE84
C S43A SE98
D T135A SE99
E S354A SE100
F S372A SE101
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vectors containing the wild-type and mutant N termini of CDC6
(pELS12, pELS32, pELS33, pELS34, pELS52, and pELS86), resulting
in plasmids pELS91, pELS92, pELS93, pELS94, and pELS95, respec-
tively.
The nuclear localization site mutation was generated by mutating
pELS12 with oligonucleotide SE72, resulting in pELS86. The PstI–
HindIII fragment from pELS60 was cloned into the same sites in
pELS86, generating pELS105.
Additional Mutagenesis of CDC6. Mutation of the CDK consensus
phosphorylation sites in CDC6 was accomplished by transforming
pELS91 into strain CJ236, producing single-stranded DNA, and
generating mutations using the Muta-Gene mutagenesis kit and the
primers shown in Tables 1 and 2. For alleles with mutations at
several sites, multiple oligonucleotides were used in a single reac-
tion. Mutagenesis using several oligonucleotides at once produced
anywhere from 10 to 90% desired products. The complete set of
mutants is listed in Table 3.
An allele of CDC6 lacking residues 8–46 was generated by swap-
ping the NdeI–PstI fragment of pELS91 with a cassette comprising of
oligonucleotides SE74 and SE75 (Table 1).
Plasmids with N-terminal Glutathione S-Transferase (GST) Tags.
For the experiment shown in Figure 8, the plasmids YGpKTU6
(bearing wild-type Cdc6p) and YGpME6 (bearing Cdc6p mutated at
lysine 114 to glutamate) were used (Elsasser et al., 1996).
Preparation of Integrating Yeast Vectors Used for the Stability
Assays in Figures 2 and 3. BamHI–HindIII fragments from the
Bluescript-based vectors containing the entire CDC6 ORF, the C-
terminal Myc9 tag, and the natural 39UTR (the same set that was
used for the in vitro ubiquitination experiments) were cloned into
pELS89 (pRS306 with the GAL promoter). For integration, vectors
were linearized at the EcoRV site within theURA3 marker.
Preparation of Vectors Used in the Two-Hybrid Assays. Vectors
with the wild-type and mutant CDC6 ORFs fused at the C terminus
of the LexA DNA binding domain were prepared by amplifying
sequences from the Bluescript constructs bearing the complete ORF
(see Table 3) with 59 oligonucleotides SE128, SE129, SE130, and
SE131 and 39 oligonucleotides SE132 and SE133 (see Table 4) and
cloning into BTM116. The assortment of oligonucleotides used at the
59 end was required to amplify mutants with engineered sequence
differences at the N terminus. Inserts generated with SE132 were
subcloned much more efficiently than inserts generated with SE133.
The two oligonucleotides are exactly the same at the 39 end, which
anneals to the last nine natural codons of CDC6. Following this,
SE132 encodes a BamHI site, and SE133 encodes a SalI site. BTM116
possesses a BamHI site followed directly by a SalI site in the
polylinker between the LexA coding region and the transcriptional
termination signals. In the cases in which SE132 was used to gen-
erate inserts, the BamHI site is maintained after the stop codons. In
the cases in which SE133 was used, this site is removed.
Cdc28p Binding
Strain BJ2168 was transformed with pELS71 through pELS75. Two
hundred-milliliter cultures were grown to midlog phase in SR-ura
(2% raffinose, 0.5% casamino acids, 1.5% yeast nitrogen base, and 20
mg/l each adenine and tryptophan). Expression of wild-type and
mutant CDC6 was induced by adding solid galactose to 2%. Cells
were harvested after 4 h, washed, resuspended in high-salt buffer
(Elsasser et al., 1996) at a concentration of 300 mg of wet cells/ml,
and lysed by bead beating (Biospec, Bartlesville, OK; Mini Bead-
beater, type BX-4), four times at 5000 rpm for 50 s each time, in the
presence of 0.5 mm Zir/Silica beads (product number 11079105Z).
The resulting extracts were diluted to 20 mg/ml, and small aliquots
were removed and mixed with equal volumes of 43 SDS-PAGE
loading buffer. Four milligrams of the remaining extract were mixed
with 2 mg of 9E10 antibody and 40 ml of 100 mg/ml protein A-
Sepharose slurry and incubated with mixing at 4°C for 90 min.
Immunoprecipitated protein was recovered, and beads were
washed thoroughly. Twenty microliters of 43 SDS-PAGE loading
buffer were added to the immunoprecipitates.
Stability Assay
Degradation in Synchronized Cells. The following experiment was
carried out at 30°C. Ten-milliliter cultures were grown overnight to
early log phase (;2 3 106 cells/ml) in YPR. Galactose was added at
a final concentration of 2% to induce CDC6 transcription, and cells
were incubated for 2 h. This induction protocol produced even
expression levels of wild-type and mutant alleles of Cdc6. We
observed that although overnight induction produced higher ex-
pression levels of stabilized Cdc6 alleles, the half-lives of various
alleles were unaffected by the long induction, indicating that the
destruction pathway is difficult ot saturate. Nocodazole was then
added to a final concentration of 15 mg/ml, and cells were incubated
for an additional 3 h. CDC6 transcription was repressed by the
Table 3. Plasmids for in vitro ubiquitination and stability studies
Sites
mutated
Bluescript
construct
GAL
plasmid
Wild type pELS91 pELS147
D8–46 pELS144 pELS148
D3–16 pELS92 pELS149
D13–26 pELS93 pELS150
D23–36 pELS94 pELS151
D33–46 pELS95 pELS152
NLS pELS105 pELS156
A pELS164 pELS176
B pELS193 pELS193
C pELS177 pELS177
D pELS165 pELS178
E pELS166 pELS179
F pELS167 pELS194
A 1 B pELS187 pELS198
B 1 C pELS162 pELS180
A 1 C pELS197 pELS199
A–C pELS188 pELS200
E 1 F pELS163 pELS181
A–F pELS159X pELS175
Table 4. Plasmids for two-hybrid assays
59 oligonucleotide 39 oligonucleotide Plasmid
Wild type SE128 SE133 pELS211
D8–48 SE131 SE133 pELS212
D3–16 SE130 SE133 pELS213
D13–26 SE129 SE132 pELS226
D23–36 SE128 SE133 pELS214
D33–46 SE128 SE133 pELS215
NLS SE128 SE133 pELS224
A 1 B SE129 SE133 pELS217
B 1 C SE128 SE133 pELS216
A 1 C SE129 SE132 pELS225
A–C SE129 SE132 pELS229
E 1 F SE128 SE132 pELS222
A–F SE129 SE132 pELS218
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addition of glucose to 2%. Samples (0.75 ml) of cells were removed
at various times after the addition of glucose and added to an equal
volume of ice-cold 23 yeast stop mix (300 mM NaCl, 100 mM NaF,
2 mM NaN3, 20 mM EDTA). Cells were recovered by two centrif-
ugations and resuspended in 200 ml of lysis Buffer (50 mM NaOH,
2% SDS, 5% b-mercaptoethanol, 10% glycerol). After vortexing,
samples were boiled for 5 min and titrated with 1N HCl to a pH of
7. Debris was removed by centrifugation at 14,000 rpm for 5 min.
The concentration of the resulting extract was ;4 mg/ml as deter-
mined by A280 and A260 readings. One hundred fifty microliters of
the clear supernatants were transferred to clean tubes and mixed
with 1 ml of bromphenol blue. Ten microliters of cleared extract
were electrophoresed on 7.5% SDS-PAGE gels and blotted to Hy-
bond nitrocellulose membranes (Amersham, Arlington Heights, IL).
Blots were stained with Ponceau-S to ensure that lanes were loaded
evenly. Blots were incubated with a 1:1000 dilution of 9E10 ascites
(Santa Cruz Biotechnology, Santa Cruz, CA) and a 1:2000 dilution of
goat anti-mouse HRP conjugate (Bio-Rad) and developed with ECL
reagents (Amersham).
Degradation in Asynchronous Cells. The procedure was the same as
for synchronous cells, but cells were grown exponentially to a
density of 1 3 107 cells/ml before induction.
In Vitro Transcription and Translation
DNA templates for transcription of Myc9-tagged alleles of Cdc6p
were prepared by PCR amplification of CDC6 sequences from Blue-
script-based plasmids listed in Table 3. The 59 primers were de-
signed to introduce the T7 promoter upstream of the CDC6 coding
region (SE108, SE134, SE135, and SE136), and the 39 primer SE37
corresponds to a sequence from the CDC6 39 UTR. These primers are
listed in Tables 1 and 2. In all cases the 59 primers anneal to the first
27 nucleotides of CDC6, which are the same as wild type in most
cases but different for the alleles with a mutation at the first CDK
consensus site (threonine 7 3 alanine) and for the deletions D3–16
and D8–46. Amplification was carried out using 1 ng of plasmid
DNA and 0.2 mM primers. DNA concentrations were determined by
densitometry using an Alpha Innotech (San Leandro, CA) gel doc-
umentation system. A DNA template for the transcription of SIC1
was prepared as described (Verma et al., 1997b). A DNA template
for the transcription of untagged CDC6 was produced by amplify-
ing the ORF from the plasmids listed in Table 3 with primers SE102
and SE103. PCR products were purified using the Qiagen (Hilden,
Germany) PCR purification kit. Transcription was carried out in a
volume of 100 ml by incubating 1 mg of DNA in the presence of 1
mM NTPs, 100 U of RNase inhibitor (Boehringer Mannheim, Indi-
anapolis, IN; product 799025; 1 U inhibits 50% of 5 ng of RNase A),
2 U of T7 RNA polymerase, and accompanying buffer (Boehringer
Mannheim) for 75 min at 37°C. Three microliters of RNA were used
directly in 20 ml of wheat germ in vitro translation reactions (Pro-
mega, Madison, WI) as per the manufacturer’s instructions.
Preparation of Fractionated Extracts for
Ubiquitination
Preparation of DEAE-fractionated cell extracts was carried out as
previously described (Verma et al., 1997b). Strain RJD885 was used
for wild-type cell extract, and strain RJD893 was used for cdc4
extracts.
Purification of Cdc34p
Cdc34p was purified as previously described (Banerjee et al., 1993).
For the experiments in Figure 4 and Figure 5, Cdc34p purified to
homogeneity was used. For the experiment in Figure 6, Cdc34p
purified through the DEAE step (25% pure) was used.
Expression of Proteins in Insect Cells
Baculoviruses used for the expression of proteins in insect cells were
as follows: vectors for the expression of GST-Cdc28-HAp, Cln2p,
Clb5p, and Cdc4p were the same as those previously described
(Feldman et al., 1997). For the production of insect cell lysates
containing Cln2p/Cdc28p and Clb5p/Cdc28p, SF9 insect cells were
coinfected with the relevant viruses at a multiplicity of infection of
10. At 42 h after infection, cells were recovered by centrifugation
and resuspended 0.1 vol in ice-cold insect cell lysis buffer (20 mM
HEPES, pH 7.4, 100 mM NaCl, 0.1% Triton-X100, 5 mM MgCl2, 5
mM EDTA, 2 mM DTT, 1 mM PMSF, 1 mg/ml leupeptin and
pepstatin, 50 mM NaF, 50 mM b-glycerophosphate). Cells were
briefly sonicated to ensure lysis. The lysate was cleared by centrif-
ugation for 15 min at 13,000 3 g, brought to a glycerol concentration
of 10%, and frozen in aliquots in liquid nitrogen.
Phosphorylation Assays
Untagged CDC6 was amplified, and 35S-labeled Cdc6p was pro-
duced by in vitro translation as described above. Two microliters of
translation product were mixed with 4 ml of insect cell lysate con-
taining GST-Cdc28-HAp and Clb5p, 2 ml of 103 reaction salts and
protease inhibitors (50 mM magnesium acetate, 10 mM DTT, 5 mM
PMSF, 100 mg/ml each leupeptin and pepstatin), 2 ml of an ATP-
regenerating system (10 mM ATP, 350 mM creatine phosphate, 20
mM HEPES, pH 7.2, 10 mM magnesium acetate, 0.5 mg/ml creatine
kinase), and 10 ml of distilled water. Half of the reaction was
quenched immediately with SDS-PAGE loading buffer, and the
other half of the reaction was incubated for 60 min at 25°C. The
reaction was stopped by the addition of SDS-PAGE loading buffer.
Ubiquitination Assays
Ubiquitination reactions were carried out by combining 1 ml of in
vitro translation mix containing substrate (Cdc6-Myc9p, 35S-labeled
Cdc6p, or 35S-labeled Sic1p), 1 ml of insect cell lysate containing
kinase, 4 ml of DEAE-fractionated yeast extract (as described above),
0.2 mg of Cdc34p (as described), 1 ml of ATP-regenerating system, 1
ml of 103 reaction salts and protease inhibitors (50 mM magnesium
acetate, 10 mM DTT, 5 mM PMSF, and mg/ml each leupeptin and
pepstatin), and 0.5 ml of 20 mg/ml bovine ubiquitin (Sigma, St.
Louis, MO). Reactions were brought to a volume of 10 ml with 20
mM HEPES, pH 7.2, 100 mM potassium acetate. Reactions were
mixed and incubated at 25°C for 1 h. Translation produced some
high-molecular-weight products, which have been previously ob-
served (Verma et al., 1997b) and are thought to be protein–RNA
adducts resulting from inefficient translation termination. Where
indicated, translation products were treated with 20 mg/ml RNase
A at 37°C for 15 min, which served to remove a small amount of
high-molecular-weight background and improved the sensitivity of
the ubiquitination assay.
Two-Hybrid Assay
Strains for the two-hybrid assay were created by transforming L40
with pairs of plasmids. All strains contained the pACT-CDC4 plas-
mid (bearing CDC4 fused to the activation domain of GAL4; Drury
et al., 1997) and one of the following: BTM116, which carries the
LexA DNA binding domain, pBTM-CDC6 (Drury et al., 1997), and
the plasmids shown in Table 4.
The two-hybrid assay was carried out essentially as described in
the Clontech (Palo Alto, CA) manual: saturated cultures of cells
were plated onto solid selective medium and incubated for 24 h at
30°C. Seventy-five-millimeter paper filters (VWR; product number
28321-055) were used to lift cells from the plates. Filters were frozen
for 10 s in liquid nitrogen, colony side up, and then thawed at room
temperature. Two clean filters were placed in a Petri dish saturated
with Z buffer. Thawed filters were placed on top of filters saturated
with Z buffer (100 mM sodium phosphate pH 7.0, 10 mM KCl, 10
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mM MgSO4, 40 mM b-mercaptoethanol, 0.3 mg/ml 5-bromo-4-
chloro-3-indolyl-b-d-galactopyranoside), and incubated at 30°C un-
til a blue color developed in the positive control (;75 min). Filters
were then dried with a heat gun, which served to stop the reaction.
RESULTS
The N Terminus of Cdc6p Contains Signals
Important for Regulated Destruction of Cdc6p
The interaction of Cdc6p with Cdc28p might serve to target
the kinase to its substrates in the replication apparatus, to
ensure efficient phosphorylation of Cdc6p, or both. To in-
vestigate the outcomes of the Cdc6p–Cdc28p interaction, we
have carried out deletion mutagenesis within the Cdc28p
binding region of Cdc6p and have changed the serines or
threonines in the six putative CDK phosphorylation sites in
Cdc6p, singly and in combination, to nonphosphorylatable
alanines (Figure 1; Proteome [http://www.proteome.com/
databases/YPD/YPDspreadsheet.html]; Holmes and So-
lomon, 1996). Genes containing these mutations were tagged
at the C termini with nine copies of the Myc epitope. The
CDC6-Myc9 fusion as well as all of the mutant cdc6-Myc9
constructs complement a cdc6 null.
Cdc6p, unlike most other DNA replication proteins, is
unstable in vivo after the G1–S transition (Piatti et al., 1995;
Drury et al., 1997). Because phosphorylation regulates de-
struction of other proteins at G1–S, for example Sic1p, we
asked whether the cdc6 mutations affected the degradation
of Cdc6p. GAL-CDC6-Myc9 wild-type and mutant strains
were grown in galactose, synchronized in G2 by the addition
of nocodazole, and then shifted to glucose medium to re-
press expression of Cdc6p. The level of Cdc6p remaining
during subsequent incubation in glucose medium was fol-
lowed by protein blotting. This strategy has been shown to
accurately reflect events that occur when Cdc6p is expressed
from its own promoter (Drury et al., 1997). Cdc6D8–46p,
lacking the entire Cdc28p binding domain, was stabilized
relative to wild type (Figures 1 and 2), in agreement with
recent results of others (Drury et al., 1997). In addition, in
comparing four smaller deletions across the N-terminal 46
amino acids, we found that only deletion of amino acids
23–36 causes significant stabilization (Figure 2).
Mutation of the Nuclear Localization Signal Leads
to Decreased Turnover of Cdc6p
Amino acids 23–36 contain a conserved nuclear localization
signal (NLS), 27PLKRKKL33, that has been shown to be
sufficient for the localization of a PLKRKKL–b-galactosidase
fusion protein to the yeast nucleus. Mutation of K29 renders
the NLS nonfunctional in this context (Jong et al., 1996). We
investigated the role of the NLS on Cdc6p stability by chang-
ing amino acids 29KRKK32 to AAAA and evaluated stability
in the assay already described. We found that this allele is
stabilized, and the effect is similar to that generated by
deleting residues 23–36. This suggests that the nuclear local-
ization signal is the key, nonredundant motif in this region
contributing to the stability of Cdc6p. Using fusions to green
fluorescent protein, we have verified that the KRKK-to-
AAAA mutant protein is found throughout the cell, in con-
trast to wild-type GFP-Cdc6p, which is found only in the
nucleus (Luo, Elsasser, and Campbell, unpublished data).
These results indicate that Cdc6p must enter the nucleus to
become susceptible to degradation, although they do not
eliminate the possibility that Cdc6p must then subsequently
be exported from the nucleus for interaction with the pro-
teasome.
Specific Phosphorylation Sites Are Required for
Cdc6p Turnover In Vivo
We next determined the stability of Cdc6 proteins contain-
ing mutations at the six putative Cdc28 phosphrylation sites.
Serines and threonines at T7TPK, T23PPR, S43PEK, T134PR,
S354PTR, and S372PVK (Figure 1) were changed to alanine,
singly and in combination. These sites are hereafter referred
to as sites A to F. The stability of the mutant proteins was
analyzed in cells arrested in G2 with nocodazole as de-
scribed in Figure 2. Mutation of the individual A, B, C, and
E sites caused no change in stability compared with wild
type (Figure 3A). Mutation of site D led to moderately
increased half-life, and mutation of site F led to significant
stabilization. The effect of changing C-terminal site F was
interesting and unanticipated for two reasons. First, previ-
ous deletion analysis had suggested that the signals control-
ling degradation were localized in the N-terminal domain
(Figure 2) (Drury et al., 1997). Second, site F lies in a region
that is dispensable for the tight binding to Clbp/Cdc28p.
The C-terminal portion of Cdc6p does appear to be phos-
phorylated by Clb5p/Cdc28p in vitro, because phosphory-
lation by Cdc28p causes reduced mobility in SDS gels only
for mutants containing phosphorylatable E and F sites (Fig-
ure 3B). Interestingly, phosphorylation of sites A–C does not
contribute to the detected electrophoretic mobility shift. Al-
though we cannot be sure that the shift is due to phosphor-
ylation, this is a likely interpretation. We have shown that a
cdc6A–F mutant is efficiently localized (Luo, Elsasser, and
Figure 1. Schematic of Cdc6 protein. (A) Schematic of the N-
terminal 48 amino acids of Cdc6 protein. The four large brackets
represent the deletions used and are labeled to show the extent of
the deletions. (B) Schematic of the entire Cdc6 protein. Black bars
represent CDK sites A–F, and the amino acid numbers are given for
consensus threonines and serines. Gray boxes indicate the ATP
binding motifs.
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Campbell, unpublished data), indicating that the stability of
cdc6-F does not derive from failure to enter the nucleus.
We also tested the stability of alleles bearing multiple mutations
in the putative Cdc28 phosphorylation sites in the Cdc6p N-
terminal Cdc28p-binding domain (Elsasser et al., 1996). The A–C
triple mutant was strongly stabilized (Figure 3A), demonstrating
the importance of phosphorylation, as opposed simply to binding
of Cdc28p, in Cdc6p degradation. The A 1 C double mutant was
as stable as the triple mutant, whereas sites B 1 C showed a
modest increase in stability, and A 1 B showed no difference from
wild type. Thus, phosphorylation of multiple sites in the N ter-
minus, as well as in the C terminus, contributes to the regulation
of Cdc6p stability. Although the stabilization of alleles mutated at
the putative Cdc28 sites only suggests an involvement of the
kinase, below we show a direct requirement for Cdc28p using an
in vitro ubiquitination system.
Figure 2. Stability of Cdc6p N-terminal deletion mutants. Strain
BJ5459 was transformed with integrating plasmids bearing wild-type
or mutant GAL-CDC6.-MYC9 (GAL plasmids described in Table 3),
and transformants carrying the integrated gene were isolated. Cells
were grown overnight in YPR to a cell density of 2 3 106 cells/ml. Solid
galactose was added to 2%, and cells were incubated for 2 h. Nocoda-
zole was added to a final concentration of 15 mg/ml, and cells were
incubated for an additional 3 h, at which point the population was
arrested, as determined by morphology and flow cytometry (our un-
published observations). Transcription was repressed by removing
cells from galactose–raffinose medium and resuspending in YPD, and
samples were taken at the times indicated. To determine levels of
Cdc6p, extracts were prepared as described in MATERIALS AND
METHODS and 10 mg of protein were electrophoresed on a 10% gel,
blotted to a polyvinylidene difluoride membrane (Millipore, Bedford,
MA), and probed with anti-myc monoclonal antibody 9E10. The num-
bers on the left refer to the amino acids deleted. NLS refers to the
KRKK to AAAA mutant described in the text.
Figure 3. Stability of Cdc6p point mutants. (A) Strain BJ5459 was
transformed with integrating plasmids bearing wild-type or mutant
GAL-CDC6-MYC9. Transformants carrying the integrated gene were
grown overnight in YPR to a cell density of 2 3 106 cells/ml. Solid
galactose was added to 2%, and cells were incubated for 2 h. Nocoda-
zole was added to a final concentration of 15 mg/ml, and cells were
incubated for an additional 3 h, at which point the population was
arrested, as determined by morphology and flow cytometry (our un-
published observations). Transcription was repressed as described,
and samples were taken at the times indicated and processed as
described in Figure 2. Extract was electrophoresed on 7.5% SDS-PAGE
gels, blotted to Hybond nitrocellulose (Amersham), probed with
monoclonal anti-myc antibody 9E10, and developed with ECL re-
agents. Mutations are described in the text. (B) Cdc6p is phosphory-
lated at the C-terminal CDK sites. Untagged CDC6 was amplified, and
35S-labeled Cdc6p was produced by in vitro translation. Phosphoryla-
tion reactions were carried out as described in MATERIALS AND
METHODS. Protein was electrophoresed on a 7.5% SDS gel (18 cm
long), at 30 mA for 3 h, dried, and autoradiographed. For each pair, the
reaction mix was quenched with SDS-PAGE loading buffer at time zero
(2) or incubated for 1 h at 30°C (1) and then mixed with loading
buffer. The allele of Cdc6p in each pair or reactions was reaction 1, wild
type; reaction 2, cdc6A–F; reaction 3, cdc6B 1 C; reaction 4, cdc6E 1 F;
reaction 5, cdc6A–C; reaction 6, cdc6E 1 F plus T356A, T370A, T371A.
Cdc28p phosphorylation of Cdc6p
Vol. 10, October 1999 3269
Roles of Phosphorylation in Degradation of Cdc6p
Several different models might explain the apparent require-
ment for phosphorylation in the degradation of Cdc6p. Be-
cause mutations in the nuclear localization site and the
phosphorylation sites each generate stable alleles of CDC6,
mutation of the phosphorylation sites could cause a local-
ization defect and consequently stability. Alternatively,
phosphorylation of Cdc6p might allow recognition of Cdc6p
by SCF-Cdc4p, ubiquitination, and targeting to the 26S pro-
teasome (Drury et al., 1997; Sanchez et al., 1999). To distin-
guish between these models, we analyzed ubiquitination of
Cdc6p in an in vitro reaction that has been shown to faith-
fully mimic in vivo events (Feldman et al., 1997; Skowyra et
al., 1997; Verma et al., 1997c). Ubiquitination of substrates in
vitro generally requires the presence of ubiquitin, ubiquitin-
activating enzyme (E1), ubiquitin-conjugating enzyme (E2),
and ubiquitin ligase (E3), the last of which is typically sub-
strate specific. Cdc34p, an E2, and SCF-Cdc4p, an E3 com-
prising Cdc4p, Cdc53p, Skp1p, and probably Rbx1p, target
the Cdc28p inhibitor Sic1p for degradation at the G1–S
phase transition (Schwob et al., 1994; Bai et al., 1996; Patton et
al., 1998; Kamura et al., 1999; Skowyra et al., 1999). This
reaction has recently been recapitulated in vitro (Feldman et
al., 1997; Skowyra et al., 1997; Verma et al., 1997c; Skowyra et
al., 1999), and we have adapted this system to the study of
Cdc6p. Because there is strong evidence that Cdc6p is de-
graded at the G1–S transition, we used fractionated extracts
prepared from cells arrested in G1 by suppressing Cln ex-
pression (Deshaies et al., 1995). These extracts are devoid of
all Cdc28 kinase activity, thus allowing us to test for a
Cdc28p requirement in the ubiquitination of Cdc6p. In ad-
dition, the DEAE fraction recovered from these extracts
contains SCF-Cdc4p (E3) but is devoid of Cdc34p (E2), al-
lowing us to ask whether Cdc34p is required for Cdc6p
ubiquitination (Verma et al., 1997c; Skowyra et al., 1999).
For our experiments, Sic1p was used as a positive control
substrate for the ubiquitination reactions. Ubiquitination of
Sic1p was first shown to require ubiquitin, the DEAE frac-
tion containing Uba1p (E1) and SCF-Cdc4p (E3), Cdc34p
(E2), and Cln2p/Cdc28p kinase (Verma et al., 1997c). When
in vitro-translated 35S-Sic1p and Cdc6-Myc9p are added to
this reconstituted system, Cdc6-Myc9p, like Sic1p, is con-
verted to more slowly migrating conjugates (Figure 4, lanes
2 and 6), indicating that Cdc6p is ubiquitinated in this re-
constituted system. Although we have not strictly demon-
strated that the modification of Cdc6p is due to ubiquitin,
this is the most likely explanation of these results, because 1)
modification of substrate by ubiquitin-like proteins has not
been shown to lead to substrate degradation; and (2) no
other modifications leading to such large shifts in mobility
and dependent on Cdc34p and/or Cdc4p (see Figures 4 and
5) have been described.
Importantly, neither Sic1p nor Cdc6p is ubiquitinated in
the absence of added Cdc28 kinase (Figure 4, lanes 1 and 4).
However, there is a significant difference between the ki-
nases required for the two different substrates. As reported
previously, Sic1p ubiquitination is preferentially stimulated
by Cln2p/Cdc28p (Figure 4, compare lanes 2 and 3) (Verma
et al., 1997c), even when sufficient Clb5/Cdc28 activity is
present to generate a quantitative electrophoretic shift of
Sic1p (Figure 4, lane 3; Feldman et al., 1997). In contrast,
Cdc6p ubiquitination is stimulated preferentially by Clb5p/
Cdc28p rather than by Cln2p/Cdc28p (Figure 4, compare
lanes 5 and 6). (We cannot resolve phosphorylated and
unphosphorylated forms of Cdc6p tagged with the Myc9
epitope.) Although it is difficult to compare the specific
activity of the two kinase preparations, the same amounts of
kinase were added to both the Sic1p and Cdc6p reactions,
and thus the reversal of efficiency represents an accurate
qualitative measure of the relative efficiency of the respec-
Figure 4. In vitro ubiquitination of Cdc6p
depends on Clbp/Cdc28p and Cdc34p. Lanes
1–6, Clb5p/Cdc28p dependence of Cdc6p
ubiquitination. Lanes 1–3, ubiquitination of
Sic1p was carried out as previously described
(Verma et al., 1997c). Lanes 1–3, in vitro ubiq-
uitination assays with 35S-labeled Sic1p, pro-
duced by in vitro translation. All reactions
contained DEAE-fractionated extract of G1-
arrested RJD885 cells, purified Cdc34p, an
ATP-regenerating system, salts, and ubiq-
uitin. Lane 1, no kinase added; lane 2, insect
cell lysate containing Clnp2/Cdc28p was add-
ed; lane 3, insect cell lysate containing Clb5p/
Cdc28p was added. Incubations were carried
out for 1 h at 25°C, treated with 20 mg/ml
RNase A for 15 min at 37°C to remove RNA–
protein adducts, and quenched with SDS-
PAGE loading buffer. Reactions were electro-
phoresed, and the gel was dried and
autoradiographed for 17 h. Bands correspond-
ing to Sic1p, phosphorylated Sic1p, and ubiquitinated Sic1p are indicated and were identified based on previous descriptions (Feldman et al.,
1997). Lanes 4–6, ubiquitination of Cdc6p. Reactions are exactly as described for lanes 1–3, respectively, except that in vitro-translated
Cdc6-Myc9p was not labeled with 35S. After electrophoresing, proteins were blotted to Hybond nitrocellulose and probed with monoclonal
anti-Myc antibody 9E10. Westerns were developed with the Super Signal luminescent reagent (Pierce, Rockford, IL). Lanes 7 and 8, Cdc34p
dependence of Cdc6p ubiquitination. All reactions contained DEAE-fractionated extract of G1 arrested RJD885 cells, insect cell lysate
containing Clb5p/Cdc28p, an ATP-regenerating system, salts, and ubiquitin. Purified Cdc34p was added (lane 8) or omitted (lane 7). Samples
were processed exactly as described for the samples shown in lanes 4–6.
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tive kinase on each substrate. We conclude that although
Sic1p ubiquitination is preferentially mediated by Cln2/
Cdc28p, Cdc6p ubiquitination is preferentially mediated by
Clb5/Cdc28p. This difference in cyclin dependence is en-
tirely consistent with the observations that Cdc6p is de-
graded during S phase when Clb5p/Cdc28p is active and is
also consistent with our observation that Cdc6p interacts
preferentially with Clbp/Cdc28ps compared with Clnp/
Cdc28ps (Elsasser et al., 1996). We do observe that Cln2p/
Cdc28p can support ubiquitination to some degree in vitro,
which was unexpected because Cdc6p is stable during most
of G1. This suggests that high levels of Cln2p/Cdc28p may
support in vivo degradation of Cdc6p. We propose that
phosphorylation of Cdc6p, primarily by a cyclinB/Cdc28
kinase, although perhaps also in part by Cln/Cdc28 kinases,
stimulates targeting of Cdc6p to the ubiquitination appara-
tus.
CDC4 and CDC34 Are Required for
Phosphorylation-dependent Ubiquitination of Cdc6p
In Vitro
Recent demonstration that Cdc6p is stabilized in a cdc4sic1D
strain suggested that SCF-Cdc4p targets phosphorylated
Cdc6p for ubiquitination rather than acting indirectly by
degrading Sic1p and thus activating Clb/Cdc28 kinase. Our
results confirm the direct targeting of Cdc6p by SCF-Cdc4p
action. As shown in Figure 4, lanes 7 and 8, formation of
high-molecular-weight conjugates of Cdc6p is dependent on
Cdc34p. To compare Cdc6p ubiquitination in the presence
and absence of Cdc4p, fractionated extracts were prepared
from both wild-type and cdc4 cells, and the fate of Cdc6p
was followed by labeling with 35S in the in vitro translation
reaction. As in Figure 4, the appearance of Cdc6 conjugates
depends on addition of Cdc34p (compare lanes 4 and 5).
Furthermore, Cdc6 conjugates were not obtained when us-
ing fractionated cdc4 extracts (Figure 5, compare lanes 5 and
10), but if insect cell lysate containing recombinant Cdc4p
was added, ubiquitination of Cdc6p was restored (Figure 5,
compare lanes 10 and 12). Naturally, Cdc6p modification
still required addition of Cdc34p (Figure 5, compare lanes 11
and 12). We conclude that the slowly migrating species are
ubiquitinated Cdc6p, because their appearance depends on
Cdc34p and Cdc4p. Although a requirement for Cdc34p and
Cdc4p in this reaction could derive from a requirement to
degrade Sic1p, we have determined that the Clb5/Cdc28
kinase added to these reactions is in considerable excess
over Sic1p. We therefore propose that Cdc34p and Cdc4p
are directly required for Cdc6p destruction and that Cdc4p
is required for the recognition of Cdc6p as a substrate for
ubiquitination. This model is consistent with the observa-
tions that Cdc6p and Cdc4p interact in a two-hybrid system
(Drury et al., 1997) and that Cdc6p is stable in G2 phase cells
in a cdc4sic1D strain (Sanchez et al., 1999).
Mapping of the Determinants in Cdc6p Required for
Ubiquitination In Vitro
Having demonstrated that Cdc6p could be ubiquitinated in
the Clb5p/Cdc28p-, Cdc34p-, and Cdc4p-dependent in vitro
reaction, we used this assay to evaluate whether the stability
of our cdc6 mutants was anticorrelated with ability to be
ubiquitinated in vitro. In each ubiquitination reaction, par-
ticipation of SCF-Cdc4p was controlled for by demonstrat-
ing dependence on Cdc34p (Figure 6). The Cdc6D8–46p,
which is stable in vivo (Figure 2; Drury et al., 1997), was not
ubiquitinated, confirming that there are determinants in the
N terminus required for in vitro ubiquitination. Deletion of
amino acids 3–16 or 13–26 did not appear to reduce ubiq-
uitination relative to wild type, and the mutants show rapid
turnover (Figure 2). Deletion of amino acids 23–36, which
deletes the NLS and one consensus CDK site and stabilizes
Cdc6p, consistently reduced but did not abolish ubiquitina-
tion. However, the stabilized NLS (KRKK) mutant was effi-
ciently ubiquitinated in vitro (Figure 6, lanes labeled NLS).
This supports our proposition that the NLS allele is stable in
vivo because of improper localization and argues against a
role for any of the lysines in constituting a ubiquitin acceptor
site. Surprisingly, we found that deletion of amino acids
33–46 significantly and reproducibly lowered but did not
abolish ubiquitination. This was unanticipated because this
mutant is as rapidly degraded as wild-type Cdc6p (Figure 2)
and suggests that there may be at least one additional,
Cdc4p independent turnover pathway (also see Figure 7).
We also tested the putative phosphorylation site mutants
for ubiquitination. As shown in Figure 6, mutations in indi-
vidual CDK sites did not abolish ubiquitination of Cdc6p.
(Normal ubiquitination of the cdc6-A mutant was observed
in other experiments, and the weak signal here derives from
an inefficient in vitro translation reaction [our unpublished
results].) Because the cdc6-D and cdc6-F mutants were stabi-
Figure 5. In vitro ubiquitination of Cdc6p is dependent on Cdc4p.
35S-Labeled Cdc6p was prepared by in vitro translation as described
in MATERIALS AND METHODS and used as a substrate for in
vitro ubiquitination reactions. Lane 1 contains the input 35S-labeled
Cdc6p without extract. Extract prepared from RJD885 cells (wild
type for ubiquitination components) was used in the ubiquitination
reactions in lanes 2–6. Extract from RJD893 cells (cdc4 and isogenic
to RJD885) was used in reactions in lanes 7–12. The complete ubiq-
uitination reaction (lanes 5 and 10) included DEAE-fractionated
extract of G1-arrested cells, purified Cdc34p, insect cell lysate con-
taining Clb5p/Cdc28p kinase, an ATP-regenerating system, salts,
and ubiquitin. The reactions in lanes 6, 11, and 12 were supple-
mented with recombinant Cdc4p purified from insect cells. Cdc34p
and Clb5p/Cdc28p were omitted where indicated.
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lized (Figure 3) and localize to the nucleus (Luo, Elsasser,
and Campbell, unpublished data), it was surprising that
they were ubiquitinated in vitro. In vivo, the mutant pro-
teins may be protected from ubiquitination or protected
from degradation at a step downstream of SCF-Cdc4p me-
diated ubiquitination, such as export from the nucleus. In
addition, either of these sites may target Cdc6p for degra-
dation by a different pathway (see Figure 9).
Although mutation of individual CDK sites did not affect
in vitro ubiquitination, strong effects were seen in multiple
mutants. Mutation of all three N-terminal CDK sites, A–C,
which generated a highly stabilized allele, also abolished
ubiquitination completely. The stabilized double mutants A
1 C and B 1 C were also significantly impaired for ubiq-
uitination in vitro (Figures 6 and 3). Simultaneous mutation
of the C-terminal sites E and F (Figure 6) did not reduce
ubiquitination, although the latter mutation stabilized
Cdc6p in vivo (Figure 3). In summary, there is a correlation
among phosphorylation of N-terminal sites, in vitro ubiq-
uitination, and rapid degradation in G2 phase. In contrast,
although C-terminal CDK sites are important for in vivo
degradation, phosphorylation of C-terminal sites is not im-
portant for ubiquitination by the SCF-Cdc4p in vitro system.
Two-Hybrid Analysis of the Interaction of Cdc6p
with Cdc4p
Because phosphorylation of Sic1p is required for recognition
by Cdc4p in SCF-Cdc4p (Feldman et al., 1997; Skowyra et al.,
1997), we wanted to test whether the observed failure in
ubiquitination of CDC6 alleles bearing mutations in the
Cdc28 consensus sites was a result of a failure in recognition
of Cdc6p by Cdc4p. To evaluate the interaction of mutant
Cdc6 proteins with Cdc4p, we used the two-hybrid system,
in which the interaction of Cdc6p and Cdc4p was initially
discovered (Drury et al., 1997). In summary, only mutants
that bind Cdc4p in the two hybrid assay are ubiquitinated in
vitro (Figures 6 and 7). This suggests that the physical in-
teraction of Cdc6p with Cdc4p is essential for modification
by this pathway. However, interaction of Cdc6p with Cdc4p
is not sufficient, because mutant A 1 C interacts with Cdc4p
in the two-hybrid assay but fails in ubiquitination in vitro
(Figure 7). In addition, in vivo degradation is not strictly
dependent on a tight Cdc4p interaction, because mutant
D33–46 interacts weakly with Cdc4p in the two-hybrid assay
and is poorly ubiquitinated in vitro but is degraded as
efficiently as wild type in vivo. The role of Cdc6 amino acids
33–46 in Cdc4p binding is not clear, but it is clear that serine
43 (CDK site C) is not required for the interaction (see Figure
7). The degradation of mutant D33–46 may be rationalized if
Cdc4p-mediated ubiquitination is more robust in vivo than
in vitro. Alternately, a Cdc4-independent targeting system
may be at work in vivo.
The C-terminal sites again fall into a separate class from
the N-terminal sites. Mutation of sites D and F does not
affect Cdc4p binding (Figure 7; our unpublished data) or
ubiquitination (Figure 6), yet the mutants D and F are sta-
bilized (Figure 3). The ability of these mutants to bind Cdc4p
strengthens the conclusion that phosphorylation of the C-
Figure 6. In vitro ubiquitination of Cdc6p mutants. Wild-type and mutant Cdc6-Myc9p were produced by in vitro translation as described
in MATERIALS AND METHODS, and ubiquitination reactions were carried out as described. For each pair of samples, the reaction in the
right lane was a complete ubiquitination reaction (DEAE-fractionated extract of G1 arrested RJD885 cells, partially purified Cdc34p, insect
cell lysate containing Clb5p/Cdc28p kinase, an ATP-regenerating system, salts, and ubiquitin). For the reactions run in the left lane, Cdc34p
was omitted. After the ubiquitination reaction, samples were treated with RNase (as in Figure 4), mixed with SDS-PAGE loading buffer, and
subjected to electrophoreses on 7.5% gels. Proteins were blotted to Hybond nitrocellulose and probed with 9E10 antibody, and the Western
blots were developed with the Super Signal luminescent reagent (Pierce).
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terminal sites regulates a different part of the destruction
pathway than phosphorylation of the N-terminal sequences,
or that C-terminal phosphorylation of Cdc6p regulates a
different degradation pathway entirely. In Schizosaccharomy-
ces pombe, two different F box proteins similar to Cdc4p are
critical for maintaining cdc181 at the proper physiological
levels, but whether their interaction with cdc181 is regulated
by differential phosphorylation has not been studied (Jalle-
palli et al., 1997; Jallepalli et al., 1998).
Tight Binding of Cdc6p to Cdc28p Is Not Required
for Rapid Degradation
The results of our earlier studies and those presented here
suggest that there may be two modes of interaction of Cdc6p
with Cdc28p: on the one hand, Cdc6p binds tightly to
Cdc28p, and on the other, Cdc6p is a substrate of Cdc28p.
These two modes of interaction may have different conse-
quences in vivo. To investigate whether tight binding of
Cdc6p to Cdc28p as well as phosphorylation of Cdc6p by
Cdc28p is required for rapid degradation of Cdc6p, we have
analyzed the interaction of Cdc6D8–46p, Cdc6D3–16p,
Cdc6D13–26p, Cdc6D23–36p, and Cdc6D33–46p with Clbp/
Cdc28p, using the Myc-tagged alleles described in Figure 1.
Extracts of cells constitutively expressing the tagged mutant
genes were immunoprecipitated with anti-myc 9E10 mono-
clonal antibody, and the immunoprecipitates were probed
for the presence of Cdc28p by Western blotting. As shown in
Figure 8, Cdc28p was present only in wild-type Cdc6-Myc9p
immunoprecipitates. Failure of the deletion mutants to in-
teract could be due either to altered structure of the deleted
proteins or to deletion of signals important for interaction.
We prefer the latter interpretation, because all mutants sup-
port growth in the absence of wild type Cdc6p (see below),
showing that at least the portion of the protein required for
replication is correctly folded. Thus, although phosphoryla-
tion by Cdc28p is required for degradation, tight binding of
Cdc28p by Cdc6p is not required for targeting to the ubiq-
uitination machinery.
Another Degradation Pathway?
At least two results presented here do not fit the model that
SCF-Cdc4p accounts for all Cdc6p turnover. First, cdc6D33–
46p is unstable even when it is highly overproduced, but it
does not bind Cdc4p. Second, mutants D and F are stable but
are ubiquitinated in vitro and bind Cdc4p efficiently. We
wished to use a simple genetic test for the involvement of
degradation pathways other than the Cdc4 pathway in
Cdc6p turnover. Constitutive expression of Cdc6p in cdc4-1
cells, as well as constitutive expression of Sic1p in cdc4 cells
has been shown to be lethal, suggesting that the degradation
pathway is saturated and that degradation of Cdc6p and
Sic1p is blocked (Bai et al., 1996; Sanchez et al., 1999). We
used a similar strategy to test whether the APC, the other
known ubiquitin ligase that targets cell cycle proteins (Pe-
ters, 1999), is involved in Cdc6p degradation. In choosing an
allele for study, we considered the report that S. cerevisiae
cdc16-264 mutants (but not all cdc16 mutants) overreplicate.
This controversial result suggests that the cdc16-264 allele
affects DNA replication (Heichman and Roberts, 1996, 1998;
Pichler et al., 1997). Unlike the case of cdc4-1 mutants, over-
expression of wild-type Cdc6p did not reduce the ability of
the cdc16 mutant to form colonies. However, Cdc28 consen-
sus site mutants cdc6A–C and cdc6A–F mutants showed a
dosage-dependent dominant lethal effect when introduced
into the cdc16 mutant. Analysis of the individual putative
CDK site mutants revealed the surprising result that muta-
tion of the C-terminal site F was sufficient to cause the
dominant lethal phenotype, whereas none of the other single
site mutants gave this effect (Figure 9). These results might
suggest that enhanced levels of Cdc6 are sufficient to satu-
rate the Cdc16 pathway. However, the stable Cdc6-D8–46
protein did not give a dominant negative effect (our unpub-
lished observations). The stabilized alleles that appear to
interact with the Cdc16 pathway belong to two classes of
stabilized mutants, those that are ubiquitinated in vitro and
those that are not, suggesting that interaction of Cdc6 with
the Cdc4 pathway is not required to interact with the Cdc16
Figure 7. Two-hybrid interaction of Cdc4p with wild-type and
mutant Cdc6p. Strains were prepared as described in MATERIALS
AND METHODS. All strains carry a plasmid bearing a truncated
allele of CDC4 fused to the activation domain of GAL4 (Drury et al.,
1997). Strains also carry BTM116-based plasmids, which bear the
lexA DNA binding domain fused to wild-type and mutant alleles of
CDC6, as indicated in the schematic. b-Galactosidase reactions were
carried out as described in MATERIALS AND METHODS.
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pathway. These data may indicate that the APC may play a
role in the regulation of Cdc6p levels and phosphorylation may
govern the interaction. However, they would also be explained
if Cdc6p participates in the same process as the APC and if
overproduction of these Cdc6 mutants inhibited that process.
DISCUSSION
The rapid degradation of yeast Cdc6p at G1–S is conserved
for homologues in other eukaryotes, although not in all,
suggesting that periodic degradation of Cdc6p is important
for regulation of cell cycle progression (Drury et al., 1997;
Williams et al., 1997; Hua and Newport, 1998; Saha et al.,
1998). In this work we have explored the role of phosphor-
ylation of Cdc6p in its regulated destruction during the
yeast cell cycle. By using an in vitro system prepared from
cells arrested at the G1–S boundary, and thus avoiding
multiple ambiguities introduced by evaluating the degrada-
tion of Cdc6p in vivo, we have demonstrated that Cdc6p is
ubiquitinated and that Cdc34p and Cdc4p, which also par-
ticipate in Cdc6p degradation in vivo, are directly involved
in ubiquitination of Cdc6p. Integrity of the three N-terminal
CDK phosphorylation sites appears to be required for Cdc4p
binding and for ubiquitination, suggesting that phosphory-
lation is required for targeting Cdc6p to the ubiquitination
machinery. We have also found that Clbp/Cdc28ps are
more effective at targeting Cdc6p for ubiquitination than are
Clnp/Cdc28ps, but that Clnp/Cdc28p can target ubiquiti-
nation. Thus, at a point at which Cln/Cdc28 complexes are
present at high concentration they could contribute to Cdc6p
turnover.
Characterization of Sic1p ubiquitination in vitro generated
a model of protein degradation in which phosphorylation of
a substrate by a cell cycle kinase triggered ubiquitination of
the substrate and consequent degradation by the protea-
some (Bai et al., 1996; Feldman et al., 1997). Here we dem-
onstrate that ubiquitination of Cdc6p is carried out in a
similar manner, in that we have generated a class of mutants
that are stabilized during G2 in vivo and defective in Cdc4-
mediated ubiquitination in vitro. However, the regulation of
Cdc6p turnover appears to be more complex than that of
Sic1p. In addition to the class of mutants in which SCF-
Cdc4p targeting defects and stabilization in G2 in vivo are
correlated, we also discovered a second class of mutants in
which SCF-Cdc4p targeting was intact and yet the proteins
were stable (NLS, cdc6-D, and cdc6-F), as well as a third class
of mutants in which SCF-Cdc4p targeting was defective but
mutants were still unstable (cdc6D33–46). The stability of the
NLS mutant likely derives from a failure to concentrate in
the nucleus. This suggests that in vivo at least one compo-
nent of the destruction apparatus may be active only on
Cdc6p once it is in the nucleus. This component could be
merely the putative essential kinase and therefore does not
rule out the possibility that the phosphorylated Cdc6 protein
is normally exported to the cytoplasm for degradation by
the proteasome.
Failure of nuclear localization does not account for the
stability of the C-terminal cdc6-D and cdc6-F, however (Luo,
Elsasser, and Campbell, unpublished results). The synergis-
tic growth defect achieved by overproducing cdc6-F in a
cdc16 mutant (Figure 9) that is defective in the APC-directed
destruction apparatus may indicate that the APC also con-
tributes to regulation of Cdc6p levels in the cell. Two path-
ways for Cdc6p degradation could be reconciled if there are
two populations of Cdc6p (perhaps bound to chromatin and
unbound) each sensitive to different destruction mecha-
nisms; or two pathways might act on the same population
but at different points in the cell cycle. A second possibility
is that the APC might just be needed to degrade some other
replication protein whose accumulation kills the cells in the
presence of excess Cdc6p. A third alternative is that the
cdc6-F mutant has a dominant negative effect on a step in
Figure 8. Interaction of mutant Cdc6p with Cdc28p. Strain BJ2168
was transformed with plasmids pELS71 (wild type), pELS72 (D3–16),
pELS73 (D13–26), pELS74 (D23–26), and pELS75 (D33–46). Cells were
grown overnight in synthetic medium prepared with raffinose and
lacking leucine. Expression of Cdc6 proteins was induced for 4 h with
2% galactose. Extracts were prepared, and immunoprecipitations were
carried out as described in MATERIALS AND METHODS. Top panel,
10 mg of protein was electrophoresed on a 10% gel, blotted to a
polyvinylidene difluoride membrane (Millipore), and probed with an-
ti-myc monoclonal antibody 9E10. The apparent molecular mass of
Cdc6-Myc9p is 120 kDa. Bottom two panels, 9E10 immunoprecipitates
were electrophoresed on a 12.5% gel and blotted to a polyvinylidene
difluoride membrane. The top half of the membrane was probed with
anti-myc monoclonal antibody 9E10 (middle panel), and the bottom
half of the membrane (bottom panel) was probed with anti-Cdc28p
polyclonal antibody RAA1. Protein blots were developed with ECL
reagents (Amersham). The lane on the left labeled C is a control for the
Cdc28p antibody reaction in which extract was run on the gel without
previous immunoprecipitation.
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mitosis that also requires full function of the APC, either the
metaphase-to-anaphase transition or mitotic exit.
The third class of mutant fails to interact with SCF-Cdc4p
but is nevertheless unstable: cdc6D33–48. The instability
could be mediated by another degradation pathway that
degrades Cdc6p that is not associated with Cdc28p, or the
residual ubiquitination may be sufficient to target this mu-
tant for degradation in vivo.
Several other proteins involved in G1–S control have been
shown to be targeted for degradation by phosphorylation:
Sic1p, Far1p, and the G1 cyclins (Willems et al., 1996; Hen-
choz et al., 1997; Verma et al., 1997a). For these G1 substrates
of the 26S proteasome, phosphorylation at multiple sites is
required for degradation, and this is also true for the S phase
substrate Cdc6p. As with Sic1p, only a subset of the CDK
sites on Cdc6p is required for ubiquitination, and no single
site is sufficient. As observed for Sic1p and Far1p but not the
G1 cyclins, phosphorylation of three N-terminal Cdc6p sites
seems to be essential specifically for binding of Cdc4p, be-
cause there is a correlation between Cdc6p phosphorylation
site mutants that cannot be phosphorylated and those that
fail to bind Cdc4p. That is, SCF-Cdc4p targets N-terminally
phosphorylated Cdc6p for destruction. The involvement of
the same SCF complex in the destruction of Sic1p and Cdc6p
suggests that the coordinate control of these processes was a
design of evolution. However, there is a significant differ-
ence between the kinases involved in the targeting of Sic1p,
Far1p, and Cdc6p for destruction. Sic1p and Far1p are pref-
erentially targeted to SCF-Cdc4p by Cln2p/Cdc28p,
whereas Cdc6p is preferentially targeted by Clb5p/Cdc28p,
at least in vitro. The sequential activation of the Clns and
Clbs might allow for staggering of the degradation of Sic1p
and Cdc6p. Thus, Cdc6p would not be degraded (and the
prereplicative complex thereby inactivated) until Sic1p is
removed and the Clb/kinases are able to execute initiation
of replication. It is important to note that although Cdc6p is
stable in elutriated G1 cells, and thus in the presence of
active Cln2p/Cdc28p, Cdc6p is unstable in cells exposed to
mating pheromone, which causes inactivation of the G1
cyclins and exit from the cell cycle (Drury et al., 1997; Jeoung
et al., 1999). Destruction of Cdc6p in cells preparing to mate
could be phosphorylation independent, or degradation may
be mediated by the MAP kinases that are induced by the
stimulation of the pheromone receptor.
Studies of the putative fission yeast Cdc6p homologue
cdc181 have shown that phosphorylation regulates cdc181,
and that high-molecular-weight conjugates of cdc181 can
form in proteasome mutants, but there is some uncertainty
as to which ubiquitin ligase mediates this process in vivo,
because both pop11 (a Cdc4p homologue) and sud11 have
been implicated (Jallepalli et al., 1997, 1998; Kominami and
Toda, 1997). Stabilizing cdc181 was found to cause unsched-
uled initiation of DNA replication (Jallepalli et al., 1998).
However, stabilizing Cdc6p does not cause the same phe-
nomenon in S. cerevisiae, pointing up a substantial difference
in the regulation. Therefore, degradation of Cdc6p cannot be
the sole factor that restrains replication initiation to once per
cell cycle. For such a key process as high-fidelity replication
of the chromosome, it is not unexpected that there would be
redundancy in the mechanism that prevents rereplication,
and arguably the fact that the overproduction of the Cdc6p
homologue in S. pombe causes overreplication is more sur-
prising than the converse (Jallepalli and Kelly, 1996; Jalle-
palli et al., 1998). In S. cerevisiae, other candidates for proteins
that may regulate rereplication are the Mcms, which have
been demonstrated to be compartmentalized over the course
of the cell cycle, and Dbf4p, which is unstable after the G1–S
transition (Dixon, Yang, and Campbell, unpublished data).
Assuming that rereplication is blocked by the destruction of
multiple targets, more than one pathway may act on these
Figure 9. Overexpression of
cdc6-Fp in a cdc16 mutant that re-
replicates its DNA is lethal. The
respective phosphorylation site
cdc6-A, -B, -C, -D, -E, or -F mutant
genes were introduced into strain
JLC1402. The transformants were
streaked on YPD (left) or YPRG
(right) plates to induce the cdc6
mutant proteins. Plates were in-
cubated at 30°C for 4 d. In the
course of carrying out these stud-
ies we discovered that JLC1402 is
a diploid, cdc16-264/1 heterozy-
gote and not a cdc16-264 haploid
as originally thought. All experi-
ments using this mutant were re-
peated in the appropriate hap-
loid, and the same results were
obtained.
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targets. If it proves to be true that DNA overreplicates in
some cdc16 mutants (Heichman and Roberts, 1996, 1998;
Pichler et al., 1997), and we think that the evidence weighs in
favor of a modest rereplication phenotype for these partic-
ular APC mutants, one or more DNA replication proteins
may be targeted for degradation by the APC. It has been
reported that Cdc6p is not stabilized in nocodazole-arrested
APC mutants (cdc16 and cdc23), which would appear to rule
out Cdc6p as an APC substrate (Drury et al., 1997). However,
it remains possible that Cdc6p in the preRC, present until
the G1–S transition and absent in nocodazole arrest, might
be susceptible to APC-mediated degradation. This model
fits the results shown in Figure 9 in which a stabilized allele
of Cdc6p in a cdc16 mutant resulted in lethality (although
other explanations for the result are possible). We expect to
find one of three things to be true in such cells: first, they
may suffer from unregulated initiation; second, initiation
itself may be impaired, which would in turn suggest a role
for both the APC and the phosphorylation of Cdc6p in
initiation; and third, cells may be arrested in G2 or M as a
consequence of failing to degrade Cdc6p and other DNA
replication proteins (Bueno and Russell, 1992). Whatever the
result, we expect that characterization of these cdc6 mutants
in different backgrounds will lead to a greater understand-
ing of the role of both Cdc6p and the APC in the control of
DNA replication in S. cerevisiae.
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